Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.030
-0.020 (-1.90%)
At close: May 29, 2026, 4:00 PM EDT
1.081
+0.051 (4.91%)
Pre-market: Jun 1, 2026, 4:00 AM EDT

Lucid Diagnostics Revenue

Lucid Diagnostics had revenue of $1.26M in the quarter ending March 31, 2026, with 51.69% growth. This brings the company's revenue in the last twelve months to $5.13M, up 23.03% year-over-year. In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth.

Revenue (ttm)
$5.13M
Revenue Growth
+23.03%
P/S Ratio
38.27
Revenue / Employee
$62,610
Employees
82
Market Cap
196.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.71M360.00K8.28%
Dec 31, 20244.35M1.92M79.00%
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen351.50M
Treace Medical Concepts207.32M
InfuSystem Holdings142.40M
RxSight127.48M
Owlet107.06M
CVRx, Inc.59.07M
Apyx Medical55.90M
TriSalus Life Sciences44.88M
Revenue Rankings